CheckMate 214: A phase III, randomized, open-label study of nivolumab combined with ipilimumab versus sunitinib monotherapy in patients with previously untreated metastatic renal cell carcinoma Meeting Abstract
| Authors: | Hammers, H. J.; Plimack, E. R.; Sternberg, C.; McDermott, D. F.; Larkin, J. M. G.; Ravaud, A.; Rini, B. I.; Sharma, P.; Bhagavatheeswaran, P.; Gagnier, P.; Motzer, R. |
| Abstract Title: | CheckMate 214: A phase III, randomized, open-label study of nivolumab combined with ipilimumab versus sunitinib monotherapy in patients with previously untreated metastatic renal cell carcinoma |
| Meeting Title: | 51st Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 33 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2015 May 29-Jun 2 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2015-05-20 |
| Language: | English |
| ACCESSION: | WOS:000358036904770 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2015.33.15_suppl.tps4578 |
| Notes: | Meeting Abstract: TPS4578 -- Source: Wos |
